natgillin/translations-raw huggingface dataset:
In accordance with Council Decision 2004/869/EC [6], the International Treaty on Plant Genetic Resources for Food and Agriculture (ITPGRFA) was approved on behalf of the Union.
V skladu s Sklepom Sveta 2004/869/ES [6] je bila Mednarodna pogodba o rastlinskih genskih virih za prehrano in kmetijstvo (MPRGV) odobrena v imenu Unije.
The ITPGRFA constitutes a specialised international access and benefit-sharing instrument within the meaning of Article 4(4) of the Nagoya Protocol that should not be affected by the rules implementing the Nagoya Protocol.
MPRGV je poseben mednarodni instrument za dostop in delitev koristi v smislu člena 4(4) Nagojskega protokola, na katerega pravila za izvajanje Nagojskega protokola ne bi smela vplivati.
Many Parties to the Nagoya Protocol, in the exercise of their sovereign rights, have decided that Plant Genetic Resources for Food and Agriculture (PGRFA) under their management and control and in the public domain, not listed in Annex I to the ITPGRFA, are also to be subject to the terms and conditions of the standard material transfer agreement (sMTA) for the purposes set out under the ITPGRFA.
Veliko pogodbenic Nagojskega protokola se je pri uresničevanju svojih suverenih pravic odločilo, da so za namene, določene v MPRGV, tudi za rastlinske genske vire za prehrano in kmetijstvo, ki jih upravljajo in nadzirajo ter so v javni rabi, a niso vključeni v Prilogo I k MPRGV, veljali pogoji tipskega sporazuma o prenosu materiala.
The Nagoya Protocol should be implemented in a manner that is mutually supportive with other international instruments that do not run counter to the Protocol’s objectives or to those of the Convention.
Nagojski protokol bi bilo treba izvajati tako, da bi se vzajemno podpiral z drugimi mednarodnimi instrumenti, ki niso v nasprotju s cilji protokola ali cilji Konvencije.
In Article 2 of the Convention, the terms ‘domesticated species’ are defined as any species in which the evolutionary process has been influenced by humans to meet their needs and ‘biotechnology’ as any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use.
V členu 2 Konvencije so opredeljene „udomačene vrste“ kot vse vrste, na katerih evolucijski proces je vplival človek, da bi zadovoljil svoje potrebe, „biotehnologija“ pa je opredeljena kot vsaka uporaba tehnologije, ki uporablja biološke sisteme, žive organizme ali njihove derivate za izdelovanje ali prilagajanje proizvodov ali postopkov za določeno uporabo.
In Article 2 of the Nagoya Protocol, the term ‘derivatives’ is defined as a naturally occurring biochemical compound resulting from the genetic expression or metabolism of biological or genetic resources, even if it does not contain functional units of heredity.
V členu 2 Nagojskega protokola so opredeljeni „derivati“ kot v naravi prisotna biokemijska spojina, ki je posledica genskega izraza ali metabolizma bioloških ali genskih virov, tudi če ne vsebuje funkcionalnih enot dednosti.
The Nagoya Protocol requires each Party thereto to pay due regard to cases of present or imminent emergencies that threaten or damage human, animal or plant health, as determined nationally or internationally.
V Nagojskem protokolu se od vsake pogodbenica protokola zahteva, da upoštevajo primere sedanjih ali bližajočih se nevarnosti, ki ogrožajo zdravje ljudi, živali ali rastlin ali mu škodujejo ter so določene na nacionalni ali mednarodni ravni.
On 24 May 2011, the Sixty-fourth World Health Assembly adopted the Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits (the ‘PIP Framework’).
Generalna skupščina Svetovne zdravstvene organizacije je na štiriinšestdesetem zasedanju 24. maja 2011 sprejela okvir pripravljenosti na pandemijo gripe za delitev virusov gripe in dostopnost cepiv in drugih koristi (v nadaljnjem besedilu: okvir PPG).
The PIP Framework applies only to influenza viruses with human pandemic potential and specifically does not apply to seasonal influenza viruses.
Okvir PPG se uporablja samo za viruse gripe, ki bi lahko povzročili pandemijo gripe pri ljudeh, in se posebej ne uporablja za viruse sezonske gripe.
The PIP Framework constitutes a specialised international access and benefit-sharing instrument that is consistent with the Nagoya Protocol and that should not be affected by the rules implementing the Nagoya Protocol.
Okvir PPG je poseben mednarodni instrument za dostop in delitev koristi, ko je skladen z Nagojskim protokolom in nanj ne bi smela vplivati pravila za izvajanje Nagojskega protokola.
It is important to include in this Regulation the definitions from the Nagoya Protocol and the Convention that are necessary for the implementation of this Regulation by users.
Pomembno je, da se v to uredbo vključijo opredelitve pojmov iz Nagojskega protokola in Konvencije, ki so potrebne, da lahko uporabniki izvajajo to uredbo.
It is important that the new definitions contained in this Regulation, which are not included in the Convention or in the Nagoya Protocol, are consistent with the definitions of the Convention and the Nagoya Protocol.
Pomembno je, da so nove opredelitve pojmov v tej uredbi, ki niso vključene v Konvencijo ali Nagojski protokol, skladne z opredelitvami pojmov iz Konvencije in Nagojskega protokola.
In particular, the term ‘user’ should be consistent with the definition of ‘utilization of genetic resources’ from the Nagoya Protocol.
Predvsem bi moral biti izraz „uporabnik“ skladen z opredelitvijo „uporaba genskih virov“ iz Nagojskega protokola.
The Nagoya Protocol lays down an obligation to promote and encourage research related to biological diversity, in particular research with non-commercial intent.
Nagojski protokol določa, da je treba podpirati in spodbujati raziskave o biotski raznovrstnosti, zlasti nekomercialne raziskave.
It is important to recall paragraph 2 of Decision II/11 of the Conference of the Parties to the Convention which reaffirms that human genetic resources are not included within the framework of the Convention.
Treba je opozoriti na odstavek 2 Sklepa II/11 konference pogodbenic Konvencije, v katerem je ponovno potrjeno, da človeški genski viri ne spadajo v okvir Konvencije.
There is currently no internationally-agreed definition of ‘traditional knowledge associated with genetic resources’.
Trenutno še ni mednarodno dogovorjene opredelitve „tradicionalnega znanja v zvezi z genskimi viri“.
Without prejudice to the competence and responsibility of the Member States for matters relating to traditional knowledge associated with genetic resources and the implementation of measures to safeguard indigenous and local communities’ interests, in order to ensure flexibility and legal certainty for providers and users, this Regulation should make reference to traditional knowledge associated with genetic resources as described in benefit-sharing agreements.
Zaradi zagotavljanja prožnosti in pravne varnosti za ponudnike in uporabnike bi bilo treba v tej uredbi navajati tradicionalno znanje v zvezi z genskimi viri, kot je opisano v sporazumih o delitvi koristi, vendar brez poseganja v pristojnost in odgovornost držav članic glede zadev, povezanih s tradicionalnim znanjem v zvezi z genskimi viri, in izvajanje ukrepov za zaščito interesov avtohtonih in lokalnih skupnosti.
With a view to ensuring the effective implementation of the Nagoya Protocol, all users of genetic resources and traditional knowledge associated with genetic resources should exercise due diligence to ascertain whether genetic resources and traditional knowledge associated with genetic resources have been accessed in accordance with applicable legal or regulatory requirements and to ensure that, where relevant, benefits are fairly and equitably shared.
Zaradi zagotavljanja učinkovitega izvajanja Nagojskega protokola bi morali vsi uporabniki genskih virov in tradicionalnega znanja v zvezi z njimi s primerno skrbnostjo preveriti, da je bil dostop do genskih virov in tradicionalnega znanja v zvezi z genskimi viri skladen z veljavnimi pravnimi ali regulativnimi zahtevami, kadar je primerno pa tudi zagotoviti, da se koristi pošteno in pravično delijo.
In that context, competent authorities should accept internationally-recognised certificates of compliance as evidence that the genetic resources covered were legally accessed and that mutually agreed terms were established for the user and the utilisation specified therein.
Pri tem bi morali pristojni organi sprejeti mednarodno priznana potrdila o skladnosti kot dokaz, da je bil dostop do genskih virov, za katere so bila izdana, zakonit ter da so bili za uporabnika in uporabo iz potrdila določeni medsebojno dogovorjeni pogoji.
The specific choices made by users as regards the tools and measures to apply in order to exercise due diligence should be supported through the recognition of best practices, as well as complementary measures in support of sectoral codes of conduct, model contractual clauses and guidelines with a view to increasing legal certainty and reducing costs.
Uporabnike bi bilo treba pri izbiri orodij in ukrepov, s katerimi je zagotovljena primerna skrbnost, podpreti s priznanjem najboljših praks in dopolnilnimi ukrepi v podporo sektorskim kodeksom ravnanja, vzorčnim pogodbenim klavzulam in smernicam, s čimer bo povečana tudi pravna varnost, stroški pa bodo nižji.
The obligation on users to keep information which is relevant for access and benefit-sharing should be limited in time and in accordance with the time-frame for potential innovation.
Obveznost uporabnikov, da hranijo informacije, ki se nanašajo na dostop in delitev koristi, bi bilo treba časovno omejiti, skladno s časovnim okvirom, potrebnim za morebitno inovacijo.
The successful implementation of the Nagoya Protocol depends on users and providers of genetic resources or of traditional knowledge associated with genetic resources negotiating mutually agreed terms that lead to fair and equitable benefit-sharing and contribute to the Nagoya Protocol’s wider objective of contributing to the conservation and sustainable use of biological diversity.
Uspešno izvajanje Nagojskega protokola je odvisno od tega, ali se uporabniki in ponudniki genskih virov ali tradicionalnega znanja v zvezi z njimi s pogajanji medsebojno dogovorijo o pogojih, ki zagotavljajo pošteno in pravično delitev koristi in prispevajo k doseganju širšega cilja Nagojskega protokola - ohranjanju biotske raznovrstnosti.
Users and providers are also encouraged to raise awareness of the importance of genetic resources and of traditional knowledge associated with genetic resources.
Uporabnike in ponudnike se tudi spodbuja, naj ozaveščajo o pomenu genskih virov in tradicionalnega znanja v zvezi z njimi.
The due diligence obligation should apply to all users irrespective of their size, including micro, small and medium-sized enterprises.
Vsi uporabniki, ne glede na velikost, tudi mikropodjetja ter mala in srednje velika podjetja, bi morali biti obvezani k primerni skrbnosti.
This Regulation should offer a range of measures and tools to enable micro, small and medium-sized enterprises to comply with their obligations at an affordable cost and with a high level of legal certainty.
V tej uredbi bi morala biti predvidena vrsta ukrepov in orodij, ki bi mikropodjetjem ter malim in srednje velikim podjetjem omogočili, da izpolnjujejo svoje obveznosti s sprejemljivimi stroški in z visoko stopnjo pravne varnosti.
Best practices developed by users should play an important role in identifying due diligence measures that are particularly suitable for achieving compliance with the system of implementation of the Nagoya Protocol at an affordable cost and with a high level of legal certainty.
Najboljše prakse, ki so jih razvili uporabniki, bi morale imeti pomembno vlogo pri prepoznavanju ukrepov za primerno skrbnost, ki so še posebej primerni za doseganje skladnosti s sistemom izvajanja Nagojskega protokola s sprejemljivimi stroški in z visoko stopnjo pravne varnosti.
Users should build on existing access and benefit-sharing codes of conduct developed for the academic, university and non-commercial research sectors and different industries.
Uporabniki bi morali ravnati na podlagi veljavnih kodeksov ravnanja za dostop in delitev koristi, ki so bili razviti za akademski, univerzitetni in nekomercialni raziskovalni sektor in različne industrijske panoge.
Associations of users should be able to request that the Commission determine whether it is possible for a specific combination of procedures, tools or mechanisms overseen by an association to be recognised as best practice.
Združenja uporabnikov bi morala imeti možnost, da zahtevajo, naj Komisija odloči, ali je mogoče posebno kombinacijo postopkov, orodij ali mehanizmov, ki jih nadzira združenje, priznati kot najboljšo prakso.
Competent authorities of the Member States should consider that the implementation of a recognised best practice by a user reduces that user’s risk of non-compliance and justifies a reduction in compliance checks.
Pristojni organi držav članic bi morali upoštevati, da je verjetnost neizpolnjevanja zahtev manjša pri uporabnikih, ki izvajajo priznane najboljše prakse, ter da je zato zanje upravičeno omejiti preglede izvajanja skladnosti.
The same should apply to best practices adopted by the Parties to the Nagoya Protocol.
Enako bi moralo veljati za najboljše prakse, ki jih sprejmejo pogodbenice Nagojskega protokola.
Under the Nagoya Protocol check-points must be effective and should be relevant to the utilisation of genetic resources.
Po Nagojskem protokolu morajo biti kontrolne točke učinkovite in bi morale biti ustrezne za uporabo genskih virov.
At identified points in the chain of activities that constitute utilisation, users should declare and provide evidence, when requested, that they have exercised due diligence.
Uporabniki bi morali na določenih točkah verige dejavnosti, ki so del uporabe, dati izjavo ter na zahtevo predložiti dokazila, da so ravnali s primerno skrbnostjo.
One suitable point for such a declaration is when research funds are received.
Med drugim je tako izjavo primerno dati ob prejemu sredstev za raziskovanje.
Another suitable point is at the final stage of utilisation, meaning at the stage of final development of a product before requesting market approval for a product developed via the utilisation of genetic resources or traditional knowledge associated with such resources, or, where market approval is not required, at the stage of final development of a product before first placing it on the Union market.
Prav tako jo je primerno dati na zadnji stopnji uporabe, to je na zadnji stopnji razvoja proizvoda, preden se zaprosi za tržno dovoljenje za proizvod, ki je bil razvit prek uporabe genskih virov ali tradicionalnega znanja v zvezi s takimi viri, oziroma, kadar dovoljenje za trženje zanj ni potrebno, na zadnji stopnji razvoja proizvoda, preden je ta prvič dan na trg Unije.
In order to ensure the effectiveness of check-points, while at the same time increasing legal certainty for users, implementing powers should be conferred on the Commission in accordance with Article 291(2) of the Treaty of the Functioning of the European Union.
Da bi zagotovili učinkovitost kontrolnih točk ter istočasno povečali pravno varnost za uporabnike, bi bilo treba na Komisijo prenesti izvedbena pooblastila v skladu s členom 291(2) Pogodbe o delovanju Evropske unije.
The Commission should make use of those implementing powers to determine the stage of final development of a product, in accordance with the Nagoya Protocol, in order to identify the final stage of utilisation in different sectors.
Komisija bi morala na podlagi teh izvedbenih pooblastil določiti zadnjo stopnjo razvoja proizvoda v skladu z Nagojskim protokolom, da bi bilo mogoče določiti zadnjo stopnjo uporabe v različnih sektorjih.
It is important to acknowledge that the Access and Benefit-Sharing Clearing House would play an important role in implementing the Nagoya Protocol.
Treba je priznati, da bi imela posredovalnica informacij o dostopu in delitvi koristi pomembno vlogo pri izvajanju Nagojskega protokola.
In accordance with Articles 14 and 17 of the Nagoya Protocol, information would be submitted to the Access and Benefit-Sharing Clearing House as part of the internationally-recognised certificate of compliance process.
V skladu s členoma 14 in 17 Nagojskega protokola bi bile informacije predložene posredovalnici informacij o dostopu in delitvi koristi med postopkom izdaje mednarodno priznanega potrdila o skladnosti.
The competent authorities should cooperate with the Access and Benefit-Sharing Clearing House to ensure that the information is exchanged to facilitate the monitoring by the competent authorities of the compliance of users.
Pristojni organi bi morali sodelovati s posredovalnico informacij, da bi zagotovili izmenjavo informacij, ki bi jim omogočile, da spremljajo, kako uporabniki izpolnjujejo obveznosti.
The collection of genetic resources in the wild is mostly undertaken for non-commercial purposes by academic, university and non-commercial researchers or collectors.
Genske vire v naravi večinoma zbirajo akademski, univerzitetni in nekomercialni raziskovalci ali zbiralci za nekomercialne namene.
In the vast majority of cases and in almost all sectors, newly-collected genetic resources are accessed through intermediaries, collections, or agents that acquire genetic resources in third countries.
V veliki večini primerov in v skoraj vseh sektorjih se do na novo zbranih genskih virov dostopa prek posrednikov, zbirk, ali agentov, ki genske vire pridobivajo v tretjih državah.
Collections are major suppliers of genetic resources and traditional knowledge associated with genetic resources utilised in the Union.
Največ genskih virov in tradicionalnega znanja v zvezi z njimi, ki se uporabljajo v Uniji, je dobavljenih iz zbirk.
As suppliers they can play an important role in helping other users in the chain of custody to comply with their obligations.
Kot dobavitelji lahko znatno pomagajo ostalim uporabnikom v verigi skrbništva pri izpolnjevanju njihovih obveznosti.
In order to do so, a system of registered collections within the Union should be put in place through the establishment of a voluntary register of collections to be maintained by the Commission.
Zato bi bilo treba vzpostaviti sistem registriranih zbirk v Uniji ter v ta namen uvesti prostovoljni register zbirk, ki bi ga vodila Komisija.
Such a system would ensure that collections included in the register effectively apply measures restricting the supply of samples of genetic resources to third persons with documentation providing evidence of legal access, and ensure the establishment of mutually agreed terms, where required.
Tak sistem bi zagotovil, da se pri zbirkah, vključenih v register, dejansko uporabljajo ukrepi, ki omejujejo dobavljanje genskih virov tretjim osebam z dokumentacijo, ki dokazuje zakonit dostop, ter zagotovil določitev medsebojno dogovorjenih pogojev, če so potrebni.
A system of registered collections within the Union should substantially lower the risk that genetic resources which were not accessed in accordance with the national access and benefit-sharing legislation or regulatory requirements of a Party to the Nagoya Protocol are utilised in the Union.
Sistem registriranih zbirk v Uniji bi moral precej zmanjšati možnost, da se v Uniji uporabljajo genski viri, ki niso bili pridobljeni v skladu z nacionalno zakonodajo ali regulativnimi zahtevami pogodbenice Nagojskega protokola, ki veljajo za dostop in delitev koristi.
The competent authorities of Member States should verify if a collection meets the requirements for recognition as a collection for inclusion in the register.
Pristojni organi držav članic bi morali preveriti, ali zbirka izpolnjuje zahteve za priznanje kot zbirka, ki se vključi v register.
Users that obtain a genetic resource from a collection included in the register should be considered to have exercised due diligence as regards the seeking of all necessary information.
Za uporabnike, ki pridobijo genske vire iz zbirke, vključene v register, bi se moralo šteti, da so pri pridobivanju vseh potrebnih informacij ravnali s primerno skrbnostjo.
This should prove particularly beneficial for academic, university and non-commercial researchers as well as small and medium-sized enterprises and should contribute to a reduction in administrative and compliance requirements.
To bi moralo koristiti zlasti akademskim, univerzitetnim in nekomercialnim raziskovalcem ter malim in srednje velikim podjetjem ter prispevati k zmanjšanju upravnih zahtev in zahtev po izpolnjevanju obveznosti.
Competent authorities of Member States should check whether users comply with their obligations, have obtained prior informed consent and have established mutually agreed terms.
Pristojni organi držav članic bi morali preveriti, ali uporabniki izpolnjujejo svoje obveznosti, so pridobili predhodno privolitev in določili vzajemno dogovorjene pogoje.
Competent authorities should also keep records of the checks made, and relevant information should be made available in accordance with Directive 2003/4/EC of the European Parliament and of the Council [7].
Pristojni organi bi morali tudi voditi evidenco, ustrezne informacije pa bi morale biti dane na voljo v skladu z Direktivo 2003/4/ES Evropskega parlamenta in Sveta [7].
Member States should ensure that infringements of the rules implementing the Nagoya Protocol are sanctioned by means of effective, proportionate and dissuasive penalties.
Države članice bi morale zagotoviti, da so kršitve pravil za izvajanje Nagojskega protokola kaznovane z učinkovitimi, sorazmernimi in odvračilnimi kaznimi.
Taking into account the international character of access and benefit-sharing transactions, competent authorities of the Member States should cooperate with each other, with the Commission, and with the competent national authorities of third countries in order to ensure that users comply with this Regulation and support an effective application of the rules implementing the Nagoya Protocol.
Zaradi mednarodnega značaja dostopa in transakcij za delitev koristi bi morali pristojni organi držav članic sodelovati med seboj, s Komisijo in pristojnimi nacionalnimi organi tretjih držav, da bi zagotovili, da uporabniki izpolnjujejo obveznosti iz te uredbe, in podprli učinkovito uporabo pravil za izvajanje Nagojskega protokola.
The Union and the Member States should act in a proactive manner to ensure that the objectives of the Nagoya Protocol are achieved in order to increase resources to support the conservation of biological diversity and the sustainable use of its components globally.
Unija in države članice bi si morale proaktivno prizadevati zagotovit, da se dosežejo cilji Nagojskega protokola, da bi tako povečali sredstva za podporo ohranjanju biotske raznovrstnosti in trajnostni rabi njenih sestavnih delov na svetovni ravni.
The Commission and the Member States should take appropriate complementary measures to enhance the effectiveness of the implementation of this Regulation and to lower costs, particularly where this would benefit academic, university and non-commercial researchers and small and medium-sized enterprises.
Komisija in države članice bi morale sprejeti ustrezne dopolnilne ukrepe za izboljšanje učinkovitosti izvajanja te uredbe in za znižanje stroškov, zlasti kadar bi to koristilo akademskim, univerzitetnim in nekomercialnim raziskovalcem ter malim in srednje velikim podjetjem.